Amsurg Corp. buy melinda
Start price
14.11.17
/
50%
€25.28
Target price
29.11.17
€45.10
Performance (%)
10.45%
End price
29.11.17
€27.93
Summary
This prediction ended on 29.11.17 with a price of €27.93. The BUY prediction by melinda finished with a performance of 10.45%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amsurg Corp. | - | - | - | - |
| iShares Core DAX® | -0.437% | -5.315% | 1.438% | 57.846% |
| iShares Nasdaq 100 | -0.194% | 3.078% | 18.683% | 84.823% |
| iShares Nikkei 225® | -0.951% | -5.884% | 27.860% | 54.805% |
| iShares S&P 500 | -0.420% | 0.922% | 13.173% | 64.029% |
Comments by melinda for this prediction
In the thread Amsurg Corp. diskutieren
SecteurInstallations und Dienstleistungen im Gesundheitswesen
- via Bloomberg
- Keybanc sagte , dass ein Angebot im niedrigen $ 40 möglich ist, während Oppenheimer des Kaufpreis Abbildung $ 50 erreichen kann.
- EVHC + 7,35% auf $ 27,75.
- Bisher: Envision Health steigt um 10% des Rückkauf Interesse (14. November)
(Vom Mitglied beendet)